Trexquant Investment LP

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 1633445 STAMFORD, CT

Position in CPRX

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$5,527,719

-$286,134 QoQ

Shares Held

223,252

-10.4% QoQ

Ownership

0.182%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2021

14 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $494,710,504 across 119 Biotechnology names. CPRX ranks #30 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	483,971	$24,585,726
2	ALNY	Alnylam Pharmaceuticals, Inc.	61,760	$20,434,531
3	ARWR	Arrowhead Pharmaceuticals, Inc.	277,114	$17,375,047
4	EXEL	Exelixis, Inc.	390,818	$16,762,184
5	HRMY	Harmony Biosciences Holdings, Inc.	594,850	$16,661,748
6	IONS	Ionis Pharmaceuticals Inc	213,645	$16,042,603
7	CNTA	Centessa Pharmaceuticals plc	390,951	$15,528,573
8	ASND	Ascendis Pharma A/S	65,517	$14,985,703

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$5,527,719	223,252	-10.4%	Shares	Sole	2026-05-15
2025-12-31	$5,813,853	249,094	+100.3%	Shares	Sole	2026-02-17
2025-09-30	$2,449,340	124,332	+193.8%	Shares	Sole	2025-11-14
2025-06-30	$918,365	42,321	-80.9%	Shares	Sole	2025-08-12
2025-03-31	$5,379,135	221,820	+7.4%	Shares	Sole	2025-05-14
2024-12-31	$4,309,425	206,489	-30.2%	Shares	Sole	2025-02-12
2024-09-30	$5,877,720	295,660	+144.9%	Shares	Sole	2024-11-12
2024-06-30	$1,870,092	120,729	+53.3%	Shares	Sole	2024-08-13
2024-03-31	$1,255,275	78,750	-46.7%	Shares	Sole	2024-05-14
2022-12-31	$2,746,420	147,657	-32.2%	Shares	Sole	2023-02-13
2022-09-30	$2,793,167	217,706	+150.4%	Shares	Sole	2022-11-14
2022-06-30	$609,526	86,951	+19.3%	Shares	Sole	2022-08-11
2022-03-31	$603,984	72,857	+40.2%	Shares	Sole	2022-05-13
2021-12-31	$351,830	51,969	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.